Serina Therapeutics, Inc. Earnings Per Share (Basic)
Serina Therapeutics, Inc. (SER) reported Earnings Per Share (Basic) of -$0.55 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Serina Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.55.
- Serina Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.58.
- Serina Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.32.
- Serina Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.45, a 381.25% decline year-over-year.
- Serina Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.91.
- Serina Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$1.51, a 163.98% decline from fiscal 2023.
- Serina Therapeutics, Inc. earnings per share, basic for fiscal 2023 was $2.36.
- Serina Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$9.70.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.55 10-Q · filed 2026-08-13 | -$1.11 10-Q · filed 2026-08-13 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.94 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.58 10-Q · filed 2026-05-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.91 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$0.45 10-Q · filed 2025-11-13 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.60 10-Q · filed 2025-11-13 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$0.66 10-Q · filed 2026-08-13 | -$1.15 10-Q · filed 2026-08-13 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.49 10-Q · filed 2026-05-14 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2024-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-03-25 | $0.44 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.51 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $0.16 10-Q · filed 2025-11-13 | $0.76 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.24 10-Q · filed 2025-11-13 | -$1.30 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||||
| 2024-06-30 | $0.61 10-Q · filed 2025-08-11 | -$1.74 10-Q · filed 2025-08-11 | -$1.92 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$1.76 derived: net income ÷ weighted average shares · filed 2025-08-11 | ||||
| 2024-03-31 | -$5.38 10-Q · filed 2025-05-08 | -$3.38 10-Q · filed 2024-05-14 | -$5.37 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$4.96 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$6.17 derived: net income ÷ weighted average shares · filed 2025-05-08 | |||
| 2023-12-31 | $0.44 derived: net income ÷ weighted average shares · filed 2025-03-24 | $1.22 derived: net income ÷ weighted average shares · filed 2025-03-24 | $2.35 derived: net income ÷ weighted average shares · filed 2025-03-24 | $2.36 10-K · filed 2025-03-24 | -$13.72 10-K · filed 2024-03-22 | |||
| 2023-09-30 | $0.80 10-Q · filed 2024-11-12 | -$0.14 10-Q · filed 2023-11-14 | $2.34 derived: net income ÷ weighted average shares · filed 2024-11-12 | $1.94 10-Q · filed 2024-11-12 | -$0.30 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.37 10-Q · filed 2024-08-09 | -$0.07 10-Q · filed 2023-08-14 | $1.14 10-Q · filed 2024-08-09 | -$0.16 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $0.77 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | -$9.70 10-K · filed 2024-03-22 | -$0.28 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | -$0.06 10-Q · filed 2023-11-14 | $133.17 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.20 10-Q · filed 2023-11-14 | $0.52 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.07 10-Q · filed 2023-08-14 | -$0.14 10-Q · filed 2023-08-14 | $0.30 derived: net income ÷ weighted average shares · filed 2023-08-14 | $0.33 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.07 10-Q · filed 2022-05-13 | $0.13 derived: net income ÷ weighted average shares · filed 2023-05-12 | $0.18 derived: net income ÷ weighted average shares · filed 2023-05-12 | $0.33 derived: net income ÷ weighted average shares · filed 2023-05-12 | ||||
| 2021-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2023-03-31 | $0.11 derived: net income ÷ weighted average shares · filed 2023-03-31 | $0.26 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.23 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$0.05 10-Q · filed 2022-11-10 | $0.23 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.17 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-12 | -$0.12 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.06 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |